Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Associacao Fraunhofer Portugal Research |
| Country | Portugal |
| Start Date | Dec 01, 2022 |
| End Date | Nov 30, 2026 |
| Duration | 1,460 days |
| Number of Grantees | 16 |
| Roles | Participant; Third Party; Associated Partner; Coordinator |
| Data Source | European Commission |
| Grant ID | 101095387 |
AISym4Med aims at developing a platform that will provide healthcare data engineers, practitioners, and researchers access to a trustworthy dataset system augmented with controlled data synthesis for experimentation and modeling purposes.
This platform will address data privacy and security by combining new anonymization techniques, attribute-based privacy measures, and trustworthy tracking systems.
Moreover, data quality controlling measures, such as unbiased data and respect to ethical norms, context-aware search, and human-centered design for validation purposes will also be implemented to guarantee the representativeness of the synthetic data generated.
Indeed, an augmentation module will be responsible for exploring and developing further the techniques of creating synthetic data, also dynamically on demand for specific use cases.
Furthermore, this platform will exploit federated technologies for reproducing un-indentifiable data from closed borders, promoting the indirect assessment of a broader number of databases, while respecting the privacy, security, and GDPR-compliant guidelines.
The proposed framework will support the development of innovative unbiased AI-based and distributed tools, technologies, and digital solutions for the benefit of researchers, patients, and providers of health services, while maintaining a high level of data privacy and ethical usage.
AISym4Med will help in the creation of more robust machine learning (ML) algorithms for real-world readiness, while considering the most effective computation configuration.
Furthermore, a machine-learning meta-engine will provide information on the quality of the generalized model by analyzing its limits and breaking points, contributing to the creation of a more robust system by supplying on-demand real and/or synthetic data.
This platform will be validated against local, national, and cross-border use-cases for both data engineers, ML developers, and aid for clinicians’ operations.
Zabala Brussels; Saidot Oy; Timelex; Zabala Innovation Consulting Sa; Imperial College of Science Technology and Medicine; Instrumentacion Y Componentes Sa; Ayesa Ibermatica Sa; Servicio Vasco de Salud Osakidetza; Consorcio Sanitario de L'Alt Penedes Y Garraf (Csapg); Tiga Bilgi Teknolojileri Anonim Sirketi; Universitair Medisch Centrum Utrecht; Asociacion Instituto de Investigacion Sanitaria Biobizkaia; Universitat Zurich; Universidade Do Porto; Associacao Fraunhofer Portugal Research; Nova Id Fct - Associacao Para A Inovacao E Desenvolvimento Da Fct
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant